R. Tsang

发表

Comparing the incidence of common adverse events of interest following influenza vaccination in the first season adjuvanted trivalent immunisation was introduced: English sentinel network annual report paper 2018/19 (Preprint)

S. de Lusignan, J. Sherlock, M. Zambon, 2020 .

S. de Lusignan, J. Sherlock, M. Zambon, 2020, JMIR Public Health and Surveillance.

Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021

S. de Lusignan, H. D. de Melker, M. Valenciano, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021

S. de Lusignan, M. Valenciano, R. Guiomar, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales

Colin Simpson, S. de Lusignan, S. Katikireddi, 2022, The Lancet.

Methodological Issues in Using a Common Data Model of COVID-19 Vaccine Uptake and Important Adverse Events of Interest: Feasibility Study of Data and Connectivity COVID-19 Vaccines Pharmacovigilance in the United Kingdom

S. de Lusignan, R. Byford, A. Sheikh, 2022, JMIR formative research.

Disparities in the excess risk of mortality in the first wave of COVID-19: Cross sectional study of the English sentinel network

S. de Lusignan, H. Liyanage, D. McGagh, 2020, Journal of Infection.

Representativeness, Vaccination Uptake, and COVID-19 Clinical Outcomes 2020-2021 in the UK Oxford-Royal College of General Practitioners Research and Surveillance Network: Cohort Profile Summary

William H. Elson, S. de Lusignan, D. Todkill, 2022, JMIR public health and surveillance.

Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network

R. Byford, Cecilia Okusi, J. Sherlock, 2022, Journal of Infection.

Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

Colin Simpson, A. Sheikh, S. de Lusignan, 2021, The Lancet.

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

S. de Lusignan, S. Katikireddi, R. Lyons, 2021, Nature Medicine.

Long covid: coding is caring

S. de Lusignan, F. Hobbs, M. Joy, 2021, BMJ.

Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study

R. Byford, John Williams, D. O’Reilly, 2023, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales

Colin Simpson, S. de Lusignan, S. Katikireddi, 2022, PLoS medicine.

Effectiveness of First Dose of COVID-19 Vaccines Against Hospital Admissions in Scotland: National Prospective Cohort Study of 5.4 Million People

Colin Simpson, A. Sheikh, S. de Lusignan, 2021, SSRN Electronic Journal.

COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study

William J. B. Midgley, S. de Lusignan, C. Jarvis, 2023, Vaccine.

Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups

S. de Lusignan, R. Byford, J. Sherlock, 2022, Journal of Infection.

Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

Colin Simpson, S. de Lusignan, S. Katikireddi, 2022, Nature Communications.

COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales

S. de Lusignan, S. Katikireddi, C. Jarvis, 2022, Vaccine.